Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic Potential
International Journal of Molecular Sciences · 23.01.2025 · 26 (3) · 944
DOI: 10.3390/ijms26030944 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.01.2025. Verfasst von Cheryl Tung und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, (Division of Cardiology), Wilf Family Cardiovascular Research Institute, Fleischer Institute for Diabetes and Metabolism (FID…. Hauptthemen laut MEDLINE: Mitochondria, Oligopeptides. Die Arbeit wurde bisher 120-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Mitochondria serve an essential metabolic and energetic role in cellular activity, and their dysfunction has been implicated in a wide range of disorders, including cardiovascular conditions, neurodegenerative disorders, and metabolic syndromes. Mitochondria-targeted therapies, such as Elamipretide (SS-31, MTP-131, Bendavia), have consequently emerged as a topic of scientific and clinical interest. Elamipretide has a unique structure allowing for uptake in a variety of cell types and highly selective mitochondrial targeting. This mitochondria-targeting tetrapeptide selectively binds cardiolipin (CL), a lipid found in the inner mitochondrial membrane, thus stabilizing mitochondrial cristae structure, reducing oxidative stress, and enhancing adenosine triphosphate (ATP) production. Preclinical studies have demonstrated the protective and restorative efficacy of Elamipretide in models of heart failure, neurodegeneration, ischemia–reperfusion injury, metabolic syndromes, and muscle atrophy and weakness. Clinical trials such as PROGRESS-HF, TAZPOWER, MMPOWER-3, and ReCLAIM elaborate on preclinical findings and highlight the significant therapeutic potential of Elamipretide. Further research may expand its application to other diseases involving mitochondrial dysfunction as well as investigate long-term efficacy and safety of the drug. The following review synthesizes current knowledge of the structure, mechanisms of action, and the promising therapeutic role of Elamipretide in stabilizing mitochondrial fitness, improving mitochondrial bioenergetics, and minimizing oxidative stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, (Division of Cardiology), Wilf Family Cardiovascular Research Institute, Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein Institute for Aging Research, Albert Einstein College of…
- Department of Molecular Pharmacology, Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Einstein Institute for Neuroimmunology and Inflammation (INI), Albert Einstein College of Medicine, New York City, NY 10461,…
- Montevergine Clinic, Mercogliano, 83013 Avellino, Italy.
ORCID-Profile: Gaetano Santulli
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
- NCATS NIH HHS
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Center for Advancing Translational Sciences
- American Heart Association
Zitieren
APA
Tung, C., Varzideh, F., Farroni, E., Mone, P., Kansakar, U., Jankauskas, S. S., & Santulli, G. (2025). Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic Potential. International Journal of Molecular Sciences, 26(3), 944. https://doi.org/10.3390/ijms26030944
Vancouver
Tung C, Varzideh F, Farroni E, Mone P, Kansakar U, Jankauskas SS, et al. Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic Potential. International Journal of Molecular Sciences. 2025;26(3):944. doi:10.3390/ijms26030944
BibTeX
@article{Tung2025,
author = {Tung, Cheryl and Varzideh, Fahimeh and Farroni, Emanuele and Mone, Pasquale and Kansakar, Urna and Jankauskas, Stanislovas S and Santulli, Gaetano},
title = {Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic Potential},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {3},
pages = {944},
doi = {10.3390/ijms26030944}
}
EUVIMED